Shandong Henglu Biotechnology Co., Ltd – Trademark Portfolio
Entity Type: 99
Shandong Henglu Biotechnology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HLMOS. The owner is based in Jinan.
No. 129 Yingxiong Shan Rd, Shizhong Dist
2904 (01), Building 1, Xiangtai Plaza
Jinan 250003 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shandong Henglu Biotechnology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shandong Henglu Biotechnology Co., Ltd have?
Shandong Henglu Biotechnology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shandong Henglu Biotechnology Co., Ltd file in?
Shandong Henglu Biotechnology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Shandong Henglu Biotechnology Co., Ltd's most well-known trademarks?
Shandong Henglu Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as HLMOS. These are among 2 currently registered trademarks in the portfolio.
What is Shandong Henglu Biotechnology Co., Ltd's trademark registration success rate?
Shandong Henglu Biotechnology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.